Bruce R Blazar

91PUBLICATIONS
547CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyRespiratory diseasesMicro- and nanosystems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (91)

|Aug 07, 2026
Chronic xenogeneic GVHD after CAR T cell therapy limits long-term safety assessment of CAR effects using NSG mouse model.

|Jul 03, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K + Supramolecular Attack Particles.

|Apr 20, 2026
Clinical outcomes of lentiviral vector gene therapy for sickle cell disease.

|Mar 02, 2026
BET inhibition blunts antibody production and macrophage-mediated fibrosis to restore lung function in murine cGVHD.

Rathan Kumar, Lotus Neidemire-Colley, Elizabeth Ar Garfinkle

|Jan 15, 2026
Regulatory T Cells and Nanomaterials: Dual Perspectives in Therapeutics and Immunomodulation.

Yiyin Chen, Haibo Huang, Xiang Wang

|Jul 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease.

Lie Ma, Brent Koehn, Michael Zaiken

Pageof 16

Frequent Collaborators

10 joint publications

Jakub Tolar

9 joint publications

Victor Tkachev

8 joint publications

Robert Zeiser

8 joint publications

Keli L Hippen